Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

BUY
$0.09 - $565.0 $1,170 - $7.35 Million
13,000 Added 33.59%
51,700 $6,000
Q2 2022

Jul 29, 2022

SELL
$0.15 - $0.54 $1,185 - $4,266
-7,900 Reduced 16.95%
38,700 $6,000
Q1 2022

May 11, 2022

SELL
$0.36 - $0.57 $1,440 - $2,280
-4,000 Reduced 7.91%
46,600 $24,000
Q3 2021

Nov 24, 2021

BUY
$0.86 - $1.21 $1,720 - $2,420
2,000 Added 4.12%
50,600 $46,000
Q2 2021

Jul 30, 2021

BUY
$1.04 - $1.69 $470 - $763
452 Added 0.94%
48,600 $58,000
Q1 2021

Apr 29, 2021

BUY
$1.32 - $3.79 $29,235 - $83,940
22,148 Added 85.18%
48,148 $78,000
Q4 2020

Jan 15, 2021

BUY
$1.06 - $1.51 $27,560 - $39,260
26,000 New
26,000 $32,000

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $5.99M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.